사코페니아 치료 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 리포트 대상 범위 : 치료 유형별, 유통 채널별, 지역별

Sarcopenia Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment Type, Distribution Channel, and Geography

US $ 4,450 ￦ 6,128,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 6,450 ￦ 8,882,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450 ￦ 11,637,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

사코페니아 치료 시장 규모는 2022년 33억 9,700만 달러에서 2030년에는 52억 6,400만 달러에 달할 것으로 예측되고 있습니다. 시장의 동향 및 사코페니아 치료 시장의 성장을 촉진·저해하는 요인을 다루고 있습니다.

근감소증과 건강에 미치는 악영향에 대한 인식이 높아짐에 따라 의료 및 노인 케어 분야의 발전에 큰 잠재력을 보여주고 있습니다. 많은 옹호 단체와 조직은 사코페니아에 대한 대중의 인식을 높이기 위해 적극적인 조치를 취하고 있습니다. 이들 단체는 종종 의료 전문가와 협력하여 신속한 진단과 치료의 가치를 강조하고 병원성, 대상 환자, 예방 및 치료와 같은 다양한 측면에 대한 최신 정보를 대중에게 제공합니다. 미국 보건복지부 여성보건국(OWH)은 2023년 여성 근감소증에 대한 인식을 확대하기 위해 'Stronger than Sarcopenia'라는 전국적인 캠페인을 시작했습니다. 미국 보건복지부의 조사에 따르면 미국 노인 인구의 45% 이상이 사코페니아을 앓고 있으며, 수백만 명의 젊은 층이 나중에 이 질환에 걸릴 위험에 처해 있습니다. 은 의료진과 함께 사코페니아에 대해 논의하고, 질병에 대한 검사를 받고, 필요한 경우 적절한 치료를 받을 것을 촉구하고 있습니다.

사르코페니아는 의대 커리큘럼과 의사, 간호사, 물리치료사 등 의료 전문가들의 교육 프로그램에도 도입되고 있습니다. 예를 들어 OWH는 Medscape Education과 협력하여 의료 전문가를 위한 CME(Continuing Medical Education) 크레딧을 만들었습니다. 주요 언론은 기사, 뉴스, 다큐멘터리 등 다양한 매체에서 사코페니아에 대한 보도를 확대하고 있으며, 2022년 2월 PubMed의 기사에 따르면 미국 보건복지부는 사코페니아에 대한 1,604건의 연구를 후원하는 미국내 최고 수준의 자금 지원 기관입니다. 는 7월 4일을 '세계 사코페니아의 날'로 지정했습니다. 이처럼 사코페니아에 대한 인식이 높아짐에 따라 향후 수년간 사코페니아 치료 시장에 새로운 성장 동력이 될 가능성이 높습니다.

치료 유형별로는 비타민 D 및 칼슘 보충제, 단백질 보충제, 비타민 B12 보충제, 기타로 구분되며, 2022년에는 비타민 D 및 칼슘 보충제 시장이 가장 큰 점유율을 차지할 것으로 예상됩니다. 이 부문의 사코페니아 치료 시장은 2022-2030년간 가장 높은 CAGR 6.5%를 나타낼 것으로 예상됩니다. 지용성 비타민인 비타민 D는 칼슘 항상성과 건강한 뼈 대사를 유지하는 데 필수적입니다. 비타민D 보충제는 근감소증의 위험을 줄이기 위한 유용한 영양 전략으로 연구되고 있습니다. 비타민D 농도가 충분하지 않은 노인은 사코페니아에 걸리기 쉽고, 종종 낙상, 입원 및 기타 부작용을 동반합니다.

캐나다 공중보건국, 미국 보건복지부, NIH는 사코페니아 치료 시장에 대한 보고서를 작성할 때 참고한 1차 및 2차 정보 중 일부입니다.

목차

제1장 서론

제2장 주요 요약

• 주요 인사이트

제3장 조사 방법

• 조사 범위
• 2차 조사
• 1차 조사

제4장 사코페니아 치료 시장 구도

• PEST 분석

제5장 사코페니아 치료 시장 : 주요 산업 역학

• 사코페니아 치료 시장 - 주요 산업 역학
• 시장 촉진요인
  • 노인 인구의 증가
  • 성인에서 영양 불량과 비타민 결핍증의 증가
• 주요 시장 억제요인
  • 직접 치료법의 입수 불가능성
• 주요 시장 기회
  • 임상시험 단계의 제품
• 향후 동향
  • 사코페니아에 대한 의식의 향상
• 촉진요인과 억제요인의 영향

제6장 사코페니아 치료 시장 : 세계 시장 분석

• 사코페니아 치료 시장 매출, 2022-2030년
• 사코페니아 치료 시장 예측과 분석

제7장 사코페니아 치료 시장 분석 : 치료 유형별

• 비타민 D 및 칼슘 보충제
• 단백질 보충제
• 비타민 B12 보충제
• 기타

제8장 사코페니아 치료 시장 분석 : 유통 채널별

• 약국
• 소매 채널
• 온라인 채널
• 기타

제9장 사코페니아 치료 시장 : 지역별 분석

• 북미
• 유럽
• 아시아태평양
• 중동 및 아프리카
• 중남미

제10장 사코페니아 치료 시장 : 업계 상황

• 사코페니아 치료 시장에서의 성장 전략
• 무기적 성장 전략
• 유기적 성장 전략

제11장 기업 개요

• Abbott Laboratories
• Bayer AG
• Metagenics LLC
• Nestle Health Science SA
• Novartis AG
• Pfizer Inc
• Sanofi SA
• Amway Corp
• GSK Plc
• Makers Nutrition LLC

제12장 부록

KSA

영문 목차

영문목차

According to our latest study on "Sarcopenia Treatment Market Forecast to 2030 - Global Analysis - Treatment Type, and Distribution Channel," the sarcopenia treatment market value is expected to reach US$ 5.264 billion by 2030 from US$ 3.397 billion in 2022. The report highlights trends prevailing in the market and factors driving and hindering the growth of the sarcopenia treatment market.

The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of pathogenicity, target patients, prevention, and treatments, among other aspects, along with underlining the value of prompt diagnosis and treatment. The Office on Women's Health (OWH) of the US Department of Health and Human Services launched the national campaign "Stronger than Sarcopenia" in 2023 to magnify the awareness of sarcopenia in women. Research by Health and Human Services shows that more than 45% of the elderly population in the US suffers from sarcopenia, and millions of younger individuals are at risk of developing this condition later in their lives. In line with OWH's "Stronger than Sarcopenia" campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required.

Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. According to a February 2022 PubMed article, the US Department of Health and Human Services is one of the top funding agencies in the US, sponsoring 1,604 studies on sarcopenia. From 2022, July 4 will be observed as World Sarcopenia Day. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years.

The sarcopenia treatment market, by treatment type, is segmented into vitamin D and calcium supplements, protein supplements, vitamin B12 supplements, and others. The vitamin D and calcium supplements segment held the largest share of the market in 2022. The sarcopenia treatment market for this segment is anticipated to record the highest CAGR of 6.5% from 2022 to 2030. Being a fat-soluble vitamin, vitamin D is crucial for maintaining calcium homeostasis and healthy bone metabolism. The supplementation of vitamin D has been studied as a useful dietary strategy to reduce the risk of sarcopenia. Older adults with suboptimal vitamin D levels are highly susceptible to sarcopenia, often associated with falls, hospitalization, and other adverse effects.

The Public Health Agency of Canada, the US Department of Health and Human Services, and NIH are a few key primary and secondary sources referred to while preparing the report on the sarcopenia treatment market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the sarcopenia treatment market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global sarcopenia treatment market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Sarcopenia Treatment Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis

5. Sarcopenia Treatment Market - Key Industry Dynamics

• 5.1 Sarcopenia Treatment Market - Key Industry Dynamics
• 5.2 Market Drivers
  • 5.2.1 Upsurge in Geriatric Population
  • 5.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
• 5.3 Key Market Restraints:
  • 5.3.1 Unavailability of Direct Interventions
• 5.4 Key Market Opportunities:
  • 5.4.1 Products in Clinical Trial Phases
• 5.5 Future Trends:
  • 5.5.1 Rising Awareness About Sarcopenia
• 5.6 Impact of Drivers and Restraints:

6. Sarcopenia Treatment Market - Global Market Analysis

• 6.1 Sarcopenia Treatment Market Revenue (US$ Million), 2022 - 2030
• 6.2 Sarcopenia Treatment Market Forecast and Analysis

7. Sarcopenia Treatment Market Analysis - By Treatment Type

• 7.1 Vitamin D and Calcium Supplement
  • 7.1.1 Overview
  • 7.1.2 Vitamin D and Calcium Supplement Market, Revenue and Forecast to 2030 (US$ Million)
• 7.2 Protein Supplement
  • 7.2.1 Overview
  • 7.2.2 Protein Supplement Market, Revenue and Forecast to 2030 (US$ Million)
• 7.3 Vitamin B12 Supplement
  • 7.3.1 Overview
  • 7.3.2 Vitamin B12 Supplement Market, Revenue and Forecast to 2030 (US$ Million)
• 7.4 Others
  • 7.4.1 Overview
  • 7.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

8. Sarcopenia Treatment Market Analysis - By Distribution Channel

• 8.1 Pharmacies
  • 8.1.1 Overview
  • 8.1.2 Pharmacies Market, Revenue and Forecast to 2030 (US$ Million)
• 8.2 Retail Channels
  • 8.2.1 Overview
  • 8.2.2 Retail Channels Market, Revenue and Forecast to 2030 (US$ Million)
• 8.3 Online Channels
  • 8.3.1 Overview
  • 8.3.2 Online Channels Market, Revenue and Forecast to 2030 (US$ Million)
• 8.4 Others
  • 8.4.1 Overview
  • 8.4.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Sarcopenia Treatment Market - Geographical Analysis

• 9.1 Overview
• 9.2 North America
  • 9.2.1 North America Sarcopenia Treatment Market Overview
  • 9.2.2 North America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • 9.2.3 North America Sarcopenia Treatment Market Breakdown by Treatment Type
    • 9.2.3.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
  • 9.2.4 North America Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.2.4.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
  • 9.2.5 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.2.5.1 North America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.2.5.2 United States Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.5.2.1 United States Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.2.5.2.2 United States Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.2.5.3 Canada Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.5.3.1 Canada Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.2.5.3.2 Canada Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.2.5.4 Mexico Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.5.4.1 Mexico Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.2.5.4.2 Mexico Sarcopenia Treatment Market Breakdown by Distribution Channel
• 9.3 Europe
  • 9.3.1 Europe Sarcopenia Treatment Market Overview
  • 9.3.2 Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • 9.3.3 Europe Sarcopenia Treatment Market Breakdown by Treatment Type
    • 9.3.3.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
  • 9.3.4 Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.3.4.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
  • 9.3.5 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.3.5.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.3.5.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.5.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.3.5.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.3.5.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.5.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.3.5.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.3.5.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.5.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.3.5.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.3.5.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.5.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.3.5.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.3.5.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.5.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.3.5.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.3.5.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.5.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.3.5.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
• 9.4 Asia Pacific
  • 9.4.1 Asia Pacific Sarcopenia Treatment Market Overview
  • 9.4.2 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • 9.4.3 Asia Pacific Sarcopenia Treatment Market Breakdown by Treatment Type
    • 9.4.3.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
  • 9.4.4 Asia Pacific Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.4.4.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
  • 9.4.5 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.4.5.1 Asia Pacific Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.4.5.2 China Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.5.2.1 China Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.4.5.2.2 China Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.4.5.3 India Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.5.3.1 India Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.4.5.3.2 India Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.4.5.4 Japan Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.5.4.1 Japan Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.4.5.4.2 Japan Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.4.5.5 South Korea Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.5.5.1 South Korea Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.4.5.5.2 South Korea Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.4.5.6 Australia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.5.6.1 Australia Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.4.5.6.2 Australia Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.4.5.7 Rest of APAC Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.5.7.1 Rest of APAC Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.4.5.7.2 Rest of APAC Sarcopenia Treatment Market Breakdown by Distribution Channel
• 9.5 Middle East and Africa
  • 9.5.1 Middle East and Africa Sarcopenia Treatment Market Overview
  • 9.5.2 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • 9.5.3 Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
    • 9.5.3.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
  • 9.5.4 Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.5.4.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
  • 9.5.5 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.5.5.1 Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.5.5.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.5.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.5.5.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.5.5.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.5.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.5.5.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.5.5.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.5.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.5.5.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.5.5.5 Rest of Middle East and Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.5.5.1 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.5.5.5.2 Rest of Middle East and Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
• 9.6 South and Central America
  • 9.6.1 South and Central America Sarcopenia Treatment Market Overview
  • 9.6.2 South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • 9.6.3 South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
    • 9.6.3.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Treatment Type
  • 9.6.4 South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.6.4.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Distribution Channel
  • 9.6.5 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.6.5.1 South and Central America Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
    • 9.6.5.2 Brazil Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.6.5.2.1 Brazil Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.6.5.2.2 Brazil Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.6.5.3 Argentina Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.6.5.3.1 Argentina Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.6.5.3.2 Argentina Sarcopenia Treatment Market Breakdown by Distribution Channel
    • 9.6.5.4 Rest of South and Central America Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.6.5.4.1 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Treatment Type
      • 9.6.5.4.2 Rest of South and Central America Sarcopenia Treatment Market Breakdown by Distribution Channel

10. Sarcopenia Treatment Market-Industry Landscape

• 10.1 Overview
• 10.2 Growth Strategies in the Sarcopenia Treatment Market
• 10.3 Inorganic Growth Strategies
  • 10.3.1 Overview
• 10.4 Organic Growth Strategies
  • 10.4.1 Overview

11. Company Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Key Facts
  • 11.1.2 Business Description
  • 11.1.3 Products and Services
  • 11.1.4 Financial Overview
  • 11.1.5 SWOT Analysis
  • 11.1.6 Key Developments
• 11.2 Bayer AG
  • 11.2.1 Key Facts
  • 11.2.2 Business Description
  • 11.2.3 Products and Services
  • 11.2.4 Financial Overview
  • 11.2.5 SWOT Analysis
  • 11.2.6 Key Developments
• 11.3 Metagenics LLC
  • 11.3.1 Key Facts
  • 11.3.2 Business Description
  • 11.3.3 Products and Services
  • 11.3.4 Financial Overview
  • 11.3.5 SWOT Analysis
  • 11.3.6 Key Developments
• 11.4 Nestle Health Science SA
  • 11.4.1 Key Facts
  • 11.4.2 Business Description
  • 11.4.3 Products and Services
  • 11.4.4 Financial Overview
  • 11.4.5 SWOT Analysis
  • 11.4.6 Key Developments
• 11.5 Novartis AG
  • 11.5.1 Key Facts
  • 11.5.2 Business Description
  • 11.5.3 Products and Services
  • 11.5.4 Financial Overview
  • 11.5.5 SWOT Analysis
  • 11.5.6 Key Developments
• 11.6 Pfizer Inc
  • 11.6.1 Key Facts
  • 11.6.2 Business Description
  • 11.6.3 Products and Services
  • 11.6.4 Financial Overview
  • 11.6.5 SWOT Analysis
  • 11.6.6 Key Developments
• 11.7 Sanofi SA
  • 11.7.1 Key Facts
  • 11.7.2 Business Description
  • 11.7.3 Products and Services
  • 11.7.4 Financial Overview
  • 11.7.5 SWOT Analysis
  • 11.7.6 Key Developments
• 11.8 Amway Corp
  • 11.8.1 Key Facts
  • 11.8.2 Business Description
  • 11.8.3 Products and Services
  • 11.8.4 Financial Overview
  • 11.8.5 SWOT Analysis
  • 11.8.6 Key Developments
• 11.9 GSK Plc
  • 11.9.1 Key Facts
  • 11.9.2 Business Description
  • 11.9.3 Products and Services
  • 11.9.4 Financial Overview
  • 11.9.5 SWOT Analysis
  • 11.9.6 Key Developments
• 11.10 Makers Nutrition LLC
  • 11.10.1 Key Facts
  • 11.10.2 Business Description
  • 11.10.3 Products and Services
  • 11.10.4 Financial Overview
  • 11.10.5 SWOT Analysis
  • 11.10.6 Key Developments

12. Appendix

• 12.1 About The Insight Partners
• 12.2 Glossary of Terms

관련자료